Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Relationships between right ventricular function, body composition, and prognosis in advanced heart failure

V. Melenovsky, M. Kotrc, BA. Borlaug, T. Marek, J. Kovar, I. Malek, J. Kautzner,

. 2013 ; 62 (18) : 1660-1670.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14050866

Grantová podpora
NT14050 MZ0 CEP - Centrální evidence projektů

OBJECTIVES: This study sought to examine the relationships between right ventricular (RV) function, body composition, and prognosis in patients with advanced heart failure (HF). BACKGROUND: Previous studies investigating HF-related cachexia have not examined the impact of RV function on body composition. We hypothesized that RV dysfunction is linked to weight loss, abnormal body composition, and worsened prognosis in advanced HF. METHODS: Subjects with advanced HF (n = 408) underwent prospective assessment of body composition (skinfold thickness, dual-energy X-ray absorptiometry), comprehensive echocardiography, and blood testing. Subjects were followed up for adverse events (defined as death, transplantation, or circulatory assist device). RESULTS: Subjects with RV dysfunction (51%) had lower body mass index, lower fat mass index, and were more likely to display cachexia (19%). The extent of RV dysfunction correlated with greater antecedent weight loss and a lower fat/lean body mass ratio. Over a median follow-up of 541 days, there were 150 events (37%). Risk of event was greater in subjects with RV dysfunction (hazard ratio: 3.09 [95% confidence interval (CI): 2.18 to 4.45]) and cachexia (hazard ratio: 2.90 [95% CI: 2.00 to 4.12]) in univariate and multivariate analyses. Increased body mass index was associated with a lower event rate (HR per kg/m(2): 0.92 [95% CI: 0.88 to 0.96]), and this protection was mediated by a higher fat mass (0.91 [95% CI: 0.87 to 0.96]) but not a fat-free mass index (0.97 [95% CI: 0.92 to 1.03]). CONCLUSIONS: RV dysfunction and cardiac cachexia often coexist, have additive adverse impact, and might be mechanistically interrelated. Wasting of fat but not of lean mass was predictive of adverse outcome, suggesting that fat loss is either a surrogate of enhanced catabolism or adipose tissue is cardioprotective in the context of HF.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14050866
003      
CZ-PrNML
005      
20190920090738.0
007      
ta
008      
140401s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jacc.2013.06.046 $2 doi
035    __
$a (PubMed)23916933
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Melenovský, Vojtěch $7 xx0160847
245    10
$a Relationships between right ventricular function, body composition, and prognosis in advanced heart failure / $c V. Melenovsky, M. Kotrc, BA. Borlaug, T. Marek, J. Kovar, I. Malek, J. Kautzner,
520    9_
$a OBJECTIVES: This study sought to examine the relationships between right ventricular (RV) function, body composition, and prognosis in patients with advanced heart failure (HF). BACKGROUND: Previous studies investigating HF-related cachexia have not examined the impact of RV function on body composition. We hypothesized that RV dysfunction is linked to weight loss, abnormal body composition, and worsened prognosis in advanced HF. METHODS: Subjects with advanced HF (n = 408) underwent prospective assessment of body composition (skinfold thickness, dual-energy X-ray absorptiometry), comprehensive echocardiography, and blood testing. Subjects were followed up for adverse events (defined as death, transplantation, or circulatory assist device). RESULTS: Subjects with RV dysfunction (51%) had lower body mass index, lower fat mass index, and were more likely to display cachexia (19%). The extent of RV dysfunction correlated with greater antecedent weight loss and a lower fat/lean body mass ratio. Over a median follow-up of 541 days, there were 150 events (37%). Risk of event was greater in subjects with RV dysfunction (hazard ratio: 3.09 [95% confidence interval (CI): 2.18 to 4.45]) and cachexia (hazard ratio: 2.90 [95% CI: 2.00 to 4.12]) in univariate and multivariate analyses. Increased body mass index was associated with a lower event rate (HR per kg/m(2): 0.92 [95% CI: 0.88 to 0.96]), and this protection was mediated by a higher fat mass (0.91 [95% CI: 0.87 to 0.96]) but not a fat-free mass index (0.97 [95% CI: 0.92 to 1.03]). CONCLUSIONS: RV dysfunction and cardiac cachexia often coexist, have additive adverse impact, and might be mechanistically interrelated. Wasting of fat but not of lean mass was predictive of adverse outcome, suggesting that fat loss is either a surrogate of enhanced catabolism or adipose tissue is cardioprotective in the context of HF.
650    _2
$a adiponektin $x krev $7 D052242
650    _2
$a věkové faktory $7 D000367
650    _2
$a složení těla $x fyziologie $7 D001823
650    _2
$a distribuce tělesného tuku $7 D050218
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a kachexie $x patofyziologie $7 D002100
650    _2
$a echokardiografie $7 D004452
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a systolické srdeční selhání $x mortalita $x patofyziologie $7 D054143
650    _2
$a srdeční frekvence $x fyziologie $7 D006339
650    _2
$a lidé $7 D006801
650    _2
$a plicní hypertenze $x patofyziologie $7 D006976
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a natriuretický peptid typu B $x krev $7 D020097
650    _2
$a prognóza $7 D011379
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a dysfunkce pravé srdeční komory $x patofyziologie $x ultrasonografie $7 D018497
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kotrč, Martin $u - $7 xx0230033
700    1_
$a Borlaug, Barry A $u -
700    1_
$a Marek, Tomáš $u - $7 xx0059973
700    1_
$a Kovář, Jan, $u - $d 1952- $7 jn20040114001
700    1_
$a Málek, Ivan, $u - $d 1942- $7 nlk20030129885
700    1_
$a Kautzner, Josef, $u - $d 1957- $7 xx0037112
773    0_
$w MED00002964 $t Journal of the American College of Cardiology $x 1558-3597 $g Roč. 62, č. 18 (2013), s. 1660-1670
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23916933 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140401 $b ABA008
991    __
$a 20190920091130 $b ABA008
999    __
$a ok $b bmc $g 1018002 $s 849446
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 62 $c 18 $d 1660-1670 $i 1558-3597 $m Journal of the American College of Cardiology $n J. Am. Coll. Cardiol. $x MED00002964
GRA    __
$a NT14050 $p MZ0
LZP    __
$a Pubmed-20140401

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...